about
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focu...
Read More
8.24
0.31
(3.91%)
46,554
XNAS Volume
XNAS 27 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Alpha Cognition Inc is on 29 Aug 2025 for the purpose of Alpha Cognition Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Alpha Cognition Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..